Status | Study |
Not yet recruiting |
Study Name: Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa Condition: Visceral Leishmaniasis Date: 2017-04-21 Interventions: Drug: Miltefosine Miltefosine |
Not yet recruiting |
Study Name: Predicting Visceral Leishmaniasis in HIV Infected Patients Condition: Leishmaniasis, Visceral Date: 2017-01-05 Interventions: Other: No intervention No intervention |
Completed |
Study Name: Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa Condition: Visceral Leishmaniasis Date: 2015-04-20 Interventions: Drug: Miltefosine |
Completed |
Study Name: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) Condition: Post-kala-azar Dermal Leishmaniasis Date: 2013-10-23 Interventions: Drug: Mitefosine Tablet Miltefosine 100 mg in two devided doses for 12 weeks |
Not yet recruiting |
Study Name: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis Condition: Visceral Leishmaniasis Date: 2012-03-27 Interventions: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS |
Terminated |
Study Name: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil Condition: Visceral Leishmaniasis Date: 2011-03-07 Interventions: Drug: Antimoniate of N-methylglucamine |
Completed |
Study Name: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh Condition: Visceral Leishmaniasis Date: 2011-01-21 Interventions: Drug: Paromomycin sulfate Paromomycin IM Injection, 11 mg/kg as the base, intramuscular, once a day on 2 |
Completed |
Study Name: A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh Condition: Visceral Leishmaniasis Date: 2010-11-07 Interventions: Drug: Randomized trial for treatment of kala azar in Bangladesh dose of SAG 20 mg/kg body weight, with a |
Completed |
Study Name: A Community Trial for Visceral Leishmaniasis (VL) Condition: Visceral Leishmaniasis Date: 2010-02-14 Interventions: Drug: Albendazole, Iron, Zinc and Vitamin A |
Completed |
Study Name: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa Condition: Primary Visceral Leishmaniasis Date: 2010-02-10 Interventions: Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate |